FHTX – foghorn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at Wall Stre
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: LaCascia Michael
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Cardama Alfonso Quintas
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Rivkin Anna
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.